Symposium VI: Small Cell Lung Cancer (SCLC) "External Control Arm":  A Paradigm Shift in Cancer Drug Evaluation/Registration

Keynotes:

“Patient-Centered Datasharing:  An Imperative for Agile Innovation”

Paul Howard, PhD, Senior Advisor to the Commissioner, FDA

"NCI Clincial Data Initiatives: Building Coalitions"

Jeff Abrams, MD, National Cancer Institute

 

Main Sessions:

Best Methods for Developing an External Control Arm

  • Brian Alexander, MD, MPH, Harvard/Dana Farber
  • Kathryn Lang, MBBS, MRCP, Pfizer
  • Yuan-Li Shen, PhD, FDA
  • Richard Simon, DSc, NCI

Key Considerations for Small Cell Lung Cancer

  • Brian Alexander, Harvard/Dana Farber
  • Renzo Canetta, MD, Senior Oncology Advisor
  • Jennifer Christian, PharmD, MPH, PhD, FISPE, IQVIA
  • Andrea Ferris, MBA, LUNGevity
  • Ariel Lopez-Chavez, MD, Roche

Attendee Institutions:

Amgen

Asana BioSciences

AstraZeneca

Bristol-Myers Squibb

Center for Medicare Services

Columbia University Medical Center

Cota Healthcare

Dana-Farber Cancer Institute

Eli Lilly & Co.

EMD Serono

Genentech

Hogan Lovells US LLP

In-Q-Tel

IQVIA

Janssen Research and Development

The Leukemia & Lymphoma Society

Life Sciences Consortium

Loxo Oncology

LUNGevity 

Massachusetts General Hospital

MD Anderson Cancer Center

Merck & Co., Inc.

National Cancer Institute, NIH

Novartis

Pfizer

Roche

R Simon Consulting